Ang-(1–7) anti-angiogenesis activities may function via the attenuation of VEGF and VEGF receptors in nasopharyngeal carcinoma (Pei et al., 2016) and in lung cancer (Soto-Pantoja et al., 2009). Here, VEGFA is linked to lung cancer.